Document complet  |  Dérouler chapitre  |  Etendre sommaire  |  Version HTML imprimable
SARS: Clinical Trials on Treatment Using a Combination of Traditional Chinese Medicine and Western Medicine
(2004; 194 pages) Voir le document au format PDF
Abrégé

This document is published as the report of the WHO International Expert Meeting to review and analyse clinical reports on combination treatment for SARS, held in Beijing, China, October 2003.

In the winter of 2002, severe acute respiratory syndrome (SARS) began to spread out to the world.  SARS is a newly identified human infection caused by a corona virus unlike any other known human or animal virus in its family.

The major challenges for the treatment of SARS are:

  • The source of the SARS virus and mode of transmission are still not well understood
  • There are problems with diagnostic tools
  • There is no effective treatment, and
  • There is no vaccine for SARS.

The above-mentioned difficulties and challenges have motivated national authorities, health workers and scientists to explore the potential of complementary treatment.

In order to better understand the potential of complementary treatment for patient with SARS and to encourage robust clinical research on SARS and its treatment with traditional medicine, WHO convened an International Expert Meeting on Review of Treatment of SARS by Traditional Chinese Medicine, and the Integration of Traditional Chinese Medicine with Western Medicine.

This publication is intended to:

  • share experience in the complementary treatment of SARS patients;
  • share the experience of clinical studies in the field of traditional medicine for treatment of SARS between the physicians and researchers; and
  • further encourage and promote the quality of research in the field of traditional medicine.
  • It must be emphasized that the purpose of this document is to report on some clinical studies on treatment and prevention selected by the Chinese government, and to record the review of these studies by an international meeting of experts.  Only national health authorities have the right to determine what treatment for SARS can be recommended.
Table des matières
Afficher le documentAcknowledgements
Afficher le documentIntroduction
Afficher le documentReport of the International Expert Meeting to review and analyse clinical reports on combination treatment for SARS
Afficher le documentReport 1: Clinical research on treatment of SARS with integrated Traditional Chinese medicine and Western Medicine
Afficher le documentReport 2: Clinical efficacy of the treatment of SARS with integrated Traditional Chinese medicine and Western medicine: an analysis of 524 cases
Afficher le documentReport 3: Manifestation of symptoms in patients with SARS and analysis of the curative effect of treatment with integrated Traditional Chinese medicine and Western medicine
Afficher le documentReport 4: Clinical study on 103 inpatients undergoing therapy with integrated Traditional Chinese medicine and Western medicine
Afficher le documentReport 5: Clinical observations of 11 patients with SARS treated with Traditional Chinese medicine
Afficher le documentReport 6: Effects of applying integrated therapy with Traditional Chinese medicine and Western medicine on liver and kidney functions in patients with SARS
Afficher le documentReport 7: Clinical research on 63 patients with SARS treated with integrated Traditional Chinese medicine and Western medicine
Afficher le documentReport 8: Influence of integrated therapy with Traditional Chinese medicine and Western medicine on lymphocytes and T-lymphocyte subpopulations of patients with SARS
Afficher le documentReport 9: Analysis of the clinical curative effects on patients with SARS of treatment with Traditional Chinese medicine and Western medicine
Afficher le documentReport 10: Evaluation of clinical curative effects of Traditional Chinese medicine in treatment of patients convalescing from SARS
Afficher le documentReport A: A herbal formula for the prevention of transmission of SARS during the SARS epidemic in Hong Kong Special Administrative Region - a prospective cohort study
Afficher le documentReport B: Effects of Chinese medicine on patients convalescing from SARS in Hong Kong special administrative region - a prospective non-randomized controlled trial
Afficher le documentReport C: Traditional Chinese medicine in the management of patients with SARS in Hong Kong Special Administrative Region - a case-control study of 24 patients
Afficher le documentAnnex
 

SARS: Clinical Trials on Treatment Using a Combination of Traditional Chinese Medicine and Western Medicine

Report of the WHO International Expert Meeting to review and analyse clinical reports on combination treatment for SARS
8-10 October 2003
Beijing, People's Republic of China

World Health Organization
Geneva
2004

WHO Library Cataloguing-in-Publication Data

SARS: Clinical trials on treatment using a combination of Traditional Chinese medicine and Western medicine

1. Severe acute respiratory syndrome -therapy 2. Medicine, Chinese traditional 3. Clinical trials 4. Cross-cultural comparison I. Title.

ISBN 92 4 154643 3

(NLM Classification: WC 505)

© World Health Organization 2004

All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to Marketing and Dissemination, at the above address (fax: +41 22 791 4806; email: permissions@who.int).

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.

Cover photograph: WHO/P. Virot

 

vers la section suivante
 
 
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 20 mars 2014